Restifo et al. (1993) J. Immunother., vol. 14, 182-190.* |
Yasutomi et al. (1995) J. Virol., vol. 69 (4), 2279-2284.* |
Saekl et. al., Development and haracerization of Cationic Liposomes Conjugated with HVJ(Sendai Virus): Reciprocal Effect of Cationic Lipid for In Vitro and In Vivom Gene Transfer, 1997; Human Gene Therapy 8: 2133-2141.* |
Ellison et. al.; Fusigenic Liposome-mediated DNA Transfer into Cardiac Myocytes, 1996, J. Mol Cell Cardiol 28: 1385-1399.* |
The Journal of Investigative Dermatology; Abstract.* |
*Okamoto, T., et al., “Induction of Antibody Response To Human Tumor Antigens By Gene Therapy Using a Fusigenic Viral Liposome Vaccine,” Gene Therapy, (Sep. 1997), 4(9), pp. 969-679. |
International Search Report, Oct. 25, 1999. |
Dzau, Victor J. et al., “Fusigenic Viral Liposome for Gene Therapy in Cardiovascular Diseases,” Proc. Natl. Acad. Sci USA, vol. 93 (Oct. 1996); pp. 11421-11425. |
Hoon et al., “Current Status of Human Melanoma Vaccines: Can They Control Malignant Melanoma?,” BioDrugs, 7:1, (Jan. 1997), pp. 66-84. |
Isaka, Yoshitaka et al., “Gene Therapy by Skeletal Muscle Expression of Decorin Prevents Fibrotic Disease in Rat Kidney,” Nature Medicine, 2:4 (Apr. 1996), pp. 418-423. |
Kaneda Y. et al., “Increased Expression of DNA Cointroduced with Nuclear Protein in Adult Rat Liver,” J. Mol. Med., 73, (1995), pp. 289-297. |
Nakamura, Norimasa et al., “Transient Introduction of a Foreign Gene into Healing Rat Patellar Ligament,” J. Clin. Invest., The American Society for Clinical Investigation, Inc., vol. 97: (Jan. 1996), pp. 226-231. |
Okamoto, T., et al., “Induction of Antibody Response to Human Tumor Antigens by Gene Therapy Using a Fusigenic Viral Liposome Vaccine,” Gene Therapy, 4 (1997), pp. 969-976. |
Wickelgren, Ingrid, “Cancer Vaccines,” Popular Science, (Jan. 1998), pp. 62-68. |
Yanagihara, I. et al., “Expression of Full-Length Human Dystrophin cDNA in mdx Mouse Muscle by HVJ-liposome Injection,” Gene Therapy, 3 (1996), pp. 549-553. |
Fukashi, Doi et al. “Detection of beta-human chorionic gonadotropin mRNA as a marker of cutaneous malignant melanoma,” Database Biosis [Online] PREV 1996 98 69 82 66 XP002143229, Abstract. |
Kawakami, Yutaka et al., “Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor,” Proc. Nat'l. Acad. Sci. USA, vol. 91, pp. 3515-3519, Apr. 1994. |
Sarantou, Terry et al., “Melanoma-associated Antigens as Messenger RNA Detection Markers for Melanoma,” Cancer Research, 57, pp. 1371-1376, Apr. 1, 1997. |
Sensi, Marialuisa et al., “Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1,” Proc. Nat'l Acad. Sci USA, vol. 92, pp. 5674-5678, Jun. 1995. |
Suzuki, Ken, et al., “In Vivo Gene Transfection with Heat Shock Protein 70 Enhances Myocardial Tolerance to Ischemia-Reperfusion Injury in Rat,” J. Clin. Invest., vol. 99, No. 7, Apr. 1997, pp. 1645-1650. |
Tuting, Thomas et al, “Autologous Human Monocyte-Derived Dendritic Cells Genetically Modified to Express Melanoma Antigens Elicit Primary Cytotoxic T Cell Response In Vitro: Enhancement by Cotransfection of Genes Encoding the Th 1-Biasing Cytokines IL-12 and IFN-α,” J. of Immun., vol. 160, No. 3, Feb. 1, 1998, pp. 1139-1147. |
Wolfe, Thomas et al., “Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes,” Eur. J. Immunol., 1994, 24: pp. 759-764. |
Yoshina, Ichiro et al., “Human Tumor-Infiltrating CD4+T Cells React to B Cell Lines Expressing Heat Shock Protein 70,” J. Immuno., vol. 153, No. 9, 1994, pp. 4149-4158. |
International Search Report, mailed Oct. 8, 2000. |
Martinon, Frederic, “Induction of virus-specific cytotoxic T lympocytes in vivo by liposome-entrapped mRNA,” Eur. J. Immunol., (1993) 23: pp. 1719-1722. |
Kaneda, Yasufumi. et al., “The Improved Efficient Method for Introducing Macromolecules into Cells Using HVJ (Sendai Virus) Liposomes with Gangliosides,” Experimental Cell Research, 173 (1987), pp. 56-69. |
Otomo, Takanobu, et al., “EBV replicon vector system enchances transgene expression in vitro: applications to cancer gene therapy,” The Journal of Gene Medicine, 2001; 3:345-352. |